The likelihood of HCV clearance was increased by participation in Ryan White services among patients with HIV coinfection.

Gilead is committed to using its virology expertise to advance HIV treatment and prevention to help end the epidemic. Since 2010, the company has partnered with Emory University in Atlanta to launch A ...

Last week, biotech bigwig Gilead Sciences, Inc. GILD reported lower-than-expected first-quarter 2025 results. Adjusted earnings per share (EPS) of $1.81 missed the Zacks Consensus Estimate by a penny.

Among programs slated for elimination are ones disproportionately impacting LBGTQ people, including HIV prevention and ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...

GSK posted higher profit as sales for its specialty treatments including HIV, cancer and asthma beat expectations, offsetting lower vaccine sales on weak demand in the U.S.

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

In a first-ever milestone, Africa’s initial HIV cure trial has yielded historic findings: 20% of patients have remained off ...

An HIV patient in Laredo is sharing his advice with others living with the disease to raise awareness and highlight available ...

An ambitious plan to stop the global threat of AIDS has been derailed. But many are hopeful that progress can be salvaged.

The US administration should clear up the confusion over the future of a widely admired AIDS fund and push for Congress to ...

Williams dedicated his life to reaching others and empowering his queer community to rise above fear. And in a powerful reminder of his lasting impact, National Black AIDS Awareness Day is observed ...